# A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery

> **NCT00398216** · PHASE2 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 903 (actual)

## Conditions studied

- Thrombosis
- Hip Replacement

## Interventions

- **DRUG:** DU176b - action is the prevention of venous thromboembolism by the use of a Factor Xa inhibitor

## Key facts

- **NCT ID:** NCT00398216
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 903 (ACTUAL)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00398216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00398216, "A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00398216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*